{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:28:41Z","timestamp":1781778521982,"version":"3.54.5"},"reference-count":85,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["2024-PS124080"],"award-info":[{"award-number":["2024-PS124080"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP210028"],"award-info":[{"award-number":["RP210028"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["1R25CA240137-01A1"],"award-info":[{"award-number":["1R25CA240137-01A1"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA16672"],"award-info":[{"award-number":["P30CA16672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007857","name":"Intellectual and Developmental Disabilities Research Center","doi-asserted-by":"publisher","award":["U54HD083092"],"award-info":[{"award-number":["U54HD083092"]}],"id":[{"id":"10.13039\/100007857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007856","name":"Baylor College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA 262324"],"award-info":[{"award-number":["R01CA 262324"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.celrep.2025.115619","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T23:31:14Z","timestamp":1745537474000},"page":"115619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of LSD1 and OXPHOS"],"prefix":"10.1016","volume":"44","author":[{"given":"Shilpa S.","family":"Dhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calena","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivareddy","family":"Kotla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Zod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janak","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ichi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veena","family":"Rajaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaifu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0859-0642","authenticated-orcid":false,"given":"Min Gyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2025.115619_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.tig.2003.09.007","article-title":"Histone lysine methylation: a signature for chromatin function","volume":"19","author":"Sims","year":"2003","journal-title":"Trends Genet."},{"key":"10.1016\/j.celrep.2025.115619_bib2","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/nrm1761","article-title":"The diverse functions of histone lysine methylation","volume":"6","author":"Martin","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.celrep.2025.115619_bib3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrg1945","article-title":"JmjC-domain-containing proteins and histone demethylation","volume":"7","author":"Klose","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.celrep.2025.115619_bib4","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1101\/gad.1652908","article-title":"Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease","volume":"22","author":"Cloos","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2025.115619_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2006.12.010","article-title":"Dynamic regulation of histone lysine methylation by demethylases","volume":"25","author":"Shi","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2025.115619_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.115619_bib7","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1126\/science.1230184","article-title":"Epigenetic reprogramming in cancer","volume":"339","author":"Suva","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115619_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-biochem-051710-134100","article-title":"The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis","volume":"81","author":"Shilatifard","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.celrep.2025.115619_bib9","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.molcel.2018.04.028","article-title":"MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes","volume":"70","author":"Dhar","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2025.115619_bib10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ccell.2020.03.005","article-title":"KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer","volume":"37","author":"Alam","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2025.115619_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108293","article-title":"Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma","volume":"33","author":"Maitituoheti","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2025.115619_bib12","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/nm.3943","article-title":"The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development","volume":"21","author":"Ortega-Molina","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.115619_bib13","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/nm.3940","article-title":"Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.115619_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ccell.2022.11.015","article-title":"KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition","volume":"41","author":"Pan","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2025.115619_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature13483","article-title":"DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier","volume":"514","author":"Santos","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.115619_bib16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ccell.2018.08.018","article-title":"HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis","volume":"34","author":"Sun","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2025.115619_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00401-012-1070-9","article-title":"Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma","volume":"125","author":"Dubuc","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2025.115619_bib18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/1235","article-title":"Pten is essential for embryonic development and tumour suppression","volume":"19","author":"Di Cristofano","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2025.115619_bib19","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1038\/leu.2014.102","article-title":"p53 haploinsufficiency and functional abnormalities in multiple myeloma","volume":"28","author":"Teoh","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.celrep.2025.115619_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1470-2045(04)01424-X","article-title":"Medulloblastoma: signalling a change in treatment","volume":"5","author":"Gilbertson","year":"2004","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.celrep.2025.115619_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ncponc0794","article-title":"Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification","volume":"4","author":"Polkinghorn","year":"2007","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.celrep.2025.115619_bib22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00401-012-0958-8","article-title":"Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas","volume":"123","author":"Kool","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2025.115619_bib23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00401-011-0922-z","article-title":"Molecular subgroups of medulloblastoma: the current consensus","volume":"123","author":"Taylor","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2025.115619_bib24","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.1073\/pnas.0832317100","article-title":"Transcriptional profiling of the Sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors","volume":"100","author":"Oliver","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.115619_bib25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature11284","article-title":"Dissecting the genomic complexity underlying medulloblastoma","volume":"488","author":"Jones","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.115619_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature11327","article-title":"Subgroup-specific structural variation across 1,000 medulloblastoma genomes","volume":"488","author":"Northcott","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.115619_bib27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature11329","article-title":"Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations","volume":"488","author":"Pugh","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.115619_bib28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1126\/science.1198056","article-title":"The genetic landscape of the childhood cancer medulloblastoma","volume":"331","author":"Parsons","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115619_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature11213","article-title":"Novel mutations target distinct subgroups of medulloblastoma","volume":"488","author":"Robinson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.115619_bib30","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nrc3410","article-title":"Medulloblastomics: the end of the beginning","volume":"12","author":"Northcott","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2025.115619_bib31","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.277.5329.1109","article-title":"Altered neural cell fates and medulloblastoma in mouse patched mutants","volume":"277","author":"Goodrich","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115619_bib32","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1242\/dev.01793","article-title":"Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma","volume":"132","author":"Oliver","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.celrep.2025.115619_bib33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/dvg.20226","article-title":"Nestin-Cre transgenic mouse line Nes-Cre1 mediates highly efficient Cre\/loxP mediated recombination in the nervous system, kidney, and somite-derived tissues","volume":"44","author":"Dubois","year":"2006","journal-title":"Genesis"},{"key":"10.1016\/j.celrep.2025.115619_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ccr.2011.12.021","article-title":"An animal model of MYC-driven medulloblastoma","volume":"21","author":"Pei","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2025.115619_bib35","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1038\/onc.2017.110","article-title":"Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells","volume":"36","author":"Kawauchi","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2025.115619_bib36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ccr.2011.12.023","article-title":"A mouse model of the most aggressive subgroup of human medulloblastoma","volume":"21","author":"Kawauchi","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2025.115619_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-9822(00)00002-6","article-title":"Tumor spectrum analysis in p53-mutant mice","volume":"4","author":"Jacks","year":"1994","journal-title":"Curr. Biol."},{"key":"10.1016\/j.celrep.2025.115619_bib38","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115619_bib39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/wdev.65","article-title":"Development of the cerebellum: from gene expression patterns to circuit maps","volume":"2","author":"White","year":"2013","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"key":"10.1016\/j.celrep.2025.115619_bib40","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00401-011-0899-7","article-title":"Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples","volume":"123","author":"Northcott","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2025.115619_bib41","doi-asserted-by":"crossref","first-page":"E4325","DOI":"10.1073\/pnas.1318639110","article-title":"Sleeping Beauty mutagenesis in a mouse medulloblastoma model defines networks that discriminate between human molecular subgroups","volume":"110","author":"Genovesi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.115619_bib42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/dvg.20633","article-title":"Generation and characterization of Atoh1-Cre knock-in mouse line","volume":"48","author":"Yang","year":"2010","journal-title":"Genesis"},{"key":"10.1016\/j.celrep.2025.115619_bib43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccr.2008.07.003","article-title":"Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells","volume":"14","author":"Yang","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2025.115619_bib44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1712","article-title":"Targeting mitochondria metabolism for cancer therapy","volume":"11","author":"Weinberg","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.celrep.2025.115619_bib45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: insights into energy pathways and therapeutic targets","volume":"23","author":"Tufail","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.celrep.2025.115619_bib46","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1002\/1873-3468.14017","article-title":"G Protein-Coupled receptors and heterotrimeric G proteins as cancer drivers","volume":"594","author":"Arang","year":"2020","journal-title":"FEBS Lett."},{"key":"10.1016\/j.celrep.2025.115619_bib47","first-page":"1629","article-title":"Upregulation of GPR34 expression affects the progression and prognosis of human gastric adenocarcinoma by PI3K\/PDK1\/AKT pathway","volume":"28","author":"Yu","year":"2013","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.celrep.2025.115619_bib48","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/leu.2016.13","article-title":"JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma","volume":"30","author":"Nairismagi","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.celrep.2025.115619_bib49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2025.115619_bib50","doi-asserted-by":"crossref","first-page":"290","DOI":"10.21037\/tcr.2018.03.02","article-title":"The overexpression of cytochrome c oxidase subunit 6C activated by Kras mutation is related to energy metabolism in pancreatic cancer","volume":"7","author":"Yang","year":"2018","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.celrep.2025.115619_bib51","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1073\/pnas.1320239111","article-title":"G-protein-coupled receptor GPR161 is overexpressed in breast cancer and is a promoter of cell proliferation and invasion","volume":"111","author":"Feigin","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.115619_bib52","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nsmb.2476","article-title":"Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo","volume":"20","author":"You","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2025.115619_bib53","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1158\/0008-5472.CAN-17-3571","article-title":"HP1gamma Promotes Lung Adenocarcinoma by Downregulating the Transcription-Repressive Regulators NCOR2 and ZBTB7A","volume":"78","author":"Alam","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2025.115619_bib54","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/nprot.2018.015","article-title":"Targeted in situ genome-wide profiling with high efficiency for low cell numbers","volume":"13","author":"Skene","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2025.115619_bib55","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1182\/blood-2011-07-368142","article-title":"Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma","volume":"120","author":"Blotta","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2025.115619_bib56","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014308","article-title":"Role of MYC in Medulloblastoma","volume":"3","author":"Roussel","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.celrep.2025.115619_bib57","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ccr.2012.04.012","article-title":"Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC","volume":"21","author":"Swartling","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2025.115619_bib58","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1101\/gad.1907510","article-title":"Pleiotropic role for MYCN in medulloblastoma","volume":"24","author":"Swartling","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2025.115619_bib59","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1158\/0008-5472.CAN-06-2973","article-title":"Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors","volume":"67","author":"Olson","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2025.115619_bib60","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1126\/science.1149042","article-title":"Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination","volume":"318","author":"Lee","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115619_bib61","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1101\/gad.203356.112","article-title":"Trans-tail regulation of MLL4-catalyzed H3K4 methylation by H4R3 symmetric dimethylation is mediated by a tandem PHD of MLL4","volume":"26","author":"Dhar","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2025.115619_bib62","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.str.2015.07.018","article-title":"Evolving Catalytic Properties of the MLL Family SET Domain","volume":"23","author":"Zhang","year":"2015","journal-title":"Structure"},{"key":"10.1016\/j.celrep.2025.115619_bib63","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01503","article-title":"H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation","volume":"2","author":"Lee","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2025.115619_bib64","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1128\/MCB.01181-13","article-title":"The MLL3\/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers","volume":"33","author":"Hu","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.celrep.2025.115619_bib65","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1093\/nar\/gkx234","article-title":"MLL3\/MLL4 are required for CBP\/p300 binding on enhancers and super-enhancer formation in brown adipogenesis","volume":"45","author":"Lai","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2025.115619_bib66","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.molcel.2017.06.028","article-title":"A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription","volume":"67","author":"Wang","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2025.115619_bib67","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nsmb.2784","article-title":"Enhancer biology and enhanceropathies","volume":"21","author":"Smith","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2025.115619_bib68","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Loven","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115619_bib69","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","article-title":"Master transcription factors and mediator establish super-enhancers at key cell identity genes","volume":"153","author":"Whyte","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115619_bib70","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","article-title":"Super-enhancers in the control of cell identity and disease","volume":"155","author":"Hnisz","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115619_bib71","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/ng.3385","article-title":"Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes","volume":"47","author":"Chen","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2025.115619_bib72","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cell.2014.06.027","article-title":"H3K4me3 breadth is linked to cell identity and transcriptional consistency","volume":"158","author":"Benayoun","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115619_bib73","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.cell.2015.08.008","article-title":"Architectural and Functional Commonalities between Enhancers and Promoters","volume":"162","author":"Kim","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115619_bib74","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature10805","article-title":"Enhancer decommissioning by LSD1 during embryonic stem cell differentiation","volume":"482","author":"Whyte","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.115619_bib75","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Bayat Mokhtari","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.celrep.2025.115619_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106114","article-title":"Mitochondria as an important target of metformin: The mechanism of action, toxic and side effects, and new therapeutic applications","volume":"177","author":"Feng","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.celrep.2025.115619_bib77","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/MOH.0b013e32834788cf","article-title":"Epigenetics and B-cell lymphoma","volume":"18","author":"Shaknovich","year":"2011","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.celrep.2025.115619_bib78","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2009.06.049","article-title":"Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes","volume":"138","author":"Wang","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115619_bib79","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.molcel.2016.06.035","article-title":"ZMYND8 Reads the Dual Histone Mark H3K4me1-H3K14ac to Antagonize the Expression of Metastasis-Linked Genes","volume":"63","author":"Li","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2025.115619_bib80","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature16546","article-title":"Active medulloblastoma enhancers reveal subgroup-specific cellular origins","volume":"530","author":"Lin","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.115619_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107831","article-title":"KMT2D suppresses Sonic hedgehog-driven medulloblastoma progression and metastasis","volume":"26","author":"Sanghrajka","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.celrep.2025.115619_bib82","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2147\/JMDH.S167808","article-title":"Medulloblastoma: optimizing care with a multidisciplinary approach","volume":"12","author":"Thomas","year":"2019","journal-title":"J. Multidiscip. Healthc."},{"key":"10.1016\/j.celrep.2025.115619_bib83","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/ITT.S198162","article-title":"Immunotherapy for Medulloblastoma: Current Perspectives","volume":"9","author":"Kabir","year":"2020","journal-title":"ImmunoTargets Ther."},{"key":"10.1016\/j.celrep.2025.115619_bib84","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","article-title":"Oxidative Phosphorylation as an Emerging Target in Cancer Therapy","volume":"24","author":"Ashton","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.115619_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1120911","article-title":"LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials","volume":"14","author":"Noce","year":"2023","journal-title":"Front. Pharmacol."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725003900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725003900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:19:43Z","timestamp":1776835183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124725003900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2211124725003900"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2025.115619","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of LSD1 and OXPHOS","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2025.115619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115619"}}